Nationwide Shortage of Albuterol Inhalers and Off-Label Use in COVID-19 Patients

被引：5
作者：
Hendeles, Leslie [1 ,2 ]
Prabhakaran, Sreekala [2 ]
机构：
[1] Univ Florida, Coll Pharm, Gainesville, FL USA
[2] Univ Florida, Dept Pediat, Gainesville, FL USA
来源：
PEDIATRIC ALLERGY IMMUNOLOGY AND PULMONOLOGY | 2020年 / 33卷 / 04期
关键词：
albuterol; COVID-19; HFA MDI; drug shortages;
D O I：
10.1089/ped.2020.1300
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
The surge in COVID-19 cases during the 2020 Spring led to a nationwide shortage of albuterol inhalers. As a new surge has begun, shortages may make it difficult for patients with obstructive lung disease, including children with asthma, to obtain refills. Since there is no evidence that albuterol relieves symptoms in COVID-19 patients with respiratory symptoms not caused by bronchospasm, it is reasonable for clinicians to not prescribe it for COVID-19 patients unless they also have asthma or chronic obstructive pulmonary disease.
引用
收藏
页码：216 / 219
页数：4
相关论文
共 20 条
  • [1] American Society of Health-System Pharmacists, 2020, DRUG SHORT LIST
  • [2] American Thoracic Society, 2020, AM J RESP CRIT CARE, V202, P13
  • [3] Nonprescription Epinephrine Metered-Dose Inhaler: To Be or Not To Be
    Blake, Kathryn
    Raissy, Hengameh
    [J]. PEDIATRIC ALLERGY IMMUNOLOGY AND PULMONOLOGY, 2014, 27 (03) : 143 - 146
  • [4] β2-Agonists and Acute Respiratory Distress Syndrome
    Budinger, G. R. Scott
    Mut, Goekhan M.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189 (06) : 624 - 625
  • [5] Scandinavian clinical practice guideline on fluid and drug therapy in adults with acute respiratory distress syndrome
    Claesson, J.
    Freundlich, M.
    Gunnarsson, I.
    Laake, J. H.
    Moller, M. H.
    Vandvik, P. O.
    Varpula, T.
    Aasmundstad, T. A.
    [J]. ACTA ANAESTHESIOLOGICA SCANDINAVICA, 2016, 60 (06) : 697 - 709
  • [6] Delivery of Medications by Metered Dose Inhaler Through a Chamber/Mask to Young Children with Asthma
    ElMallah, Mai K.
    Hendeles, Leslie
    [J]. PEDIATRIC ALLERGY IMMUNOLOGY AND PULMONOLOGY, 2012, 25 (04) : 236 - 239
  • [7] FDA, 2020, SEARCH LIST EXT US D
  • [8] FDA, 2020, FDA APPR 1 GEN COMM
  • [9] FDA, 2020, FDA APPR 1 GEN PROAI
  • [10] Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study
    Grasselli, Giacomo
    Tonetti, Tommaso
    Protti, Alessandro
    Langer, Thomas
    Girardis, Massimo
    Bellani, Giacomo
    Laffey, John
    Carrafiello, Gianpaolo
    Carsana, Luca
    Rizzuto, Chiara
    Zanella, Alberto
    Scaravilli, Vittorio
    Pizzilli, Giacinto
    Grieco, Domenico Luca
    Di Meglio, Letizia
    de Pascale, Gennaro
    Lanza, Ezio
    Monteduro, Francesco
    Zompatori, Maurizio
    Filippini, Claudia
    Locatelli, Franco
    Cecconi, Maurizio
    Fumagalli, Roberto
    Nava, Stefano
    Vincent, Jean-Louis
    Antonelli, Massimo
    Slutsky, Arthur S.
    Pesenti, Antonio
    Ranieri, V. Marco
    [J]. LANCET RESPIRATORY MEDICINE, 2020, 8 (12) : 1201 - 1208
12